We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COST icon
76
Costco
COST
$435B
$48.5M 0.28%
54,686
-24,871
-31% -$21.6M
KEYS icon
77
Keysight
KEYS
$51.5B
$48.1M 0.28%
302,404
-2,377
-0.8% -$338K
OTIS icon
78
Otis Worldwide
OTIS
$28.5B
$47.4M 0.27%
456,100
+163,470
+56% +$15.6M
ADP icon
79
Automatic Data Processing
ADP
$105B
$47.3M 0.27%
170,992
+875
+0.5% +$229K
SYK icon
80
Stryker
SYK
$134B
$46.6M 0.27%
128,991
-22,974
-15% -$7.93M
AWK icon
81
American Water Works
AWK
$27B
$45.6M 0.26%
312,129
-49,545
-14% -$7.02M
ROK icon
82
Rockwell Automation
ROK
$51.4B
$44.8M 0.26%
166,830
-1,765
-1% -$469K
HCA icon
83
HCA Healthcare
HCA
$89.9B
$44.5M 0.26%
109,488
+18,845
+21% +$6.9M
JNJ icon
84
Johnson & Johnson
JNJ
$660B
$43M 0.25%
265,152
-15,083
-5% -$2.4M
AMP icon
85
Ameriprise Financial
AMP
$48B
$42.4M 0.24%
90,300
-580
-0.6% -$252K
MCK icon
86
McKesson
MCK
$103B
$42.3M 0.24%
85,466
-1,468
-2% -$817K
ASND icon
87
Ascendis Pharma A/S
ASND
$16.4B
$42.2M 0.24%
282,331
+86,984
+45% +$11.7M
BMY icon
88
Bristol-Myers Squibb
BMY
$132B
$42M 0.24%
811,645
+119,440
+17% +$5.6M
MRNA icon
89
Moderna
MRNA
$21.5B
$41.9M 0.24%
627,666
+145,614
+30% +$13.4M
OLED icon
90
Universal Display
OLED
$3.78B
$41.6M 0.24%
197,987
-1,780
-0.9% -$361K
SNPS icon
91
Synopsys
SNPS
$74.6B
$41.4M 0.24%
81,769
+18,371
+29% +$9.86M
BIIB icon
92
Biogen
BIIB
$29.8B
$41.2M 0.24%
212,457
-54,002
-20% -$11.3M
PNC icon
93
PNC Financial Services
PNC
$100B
$41M 0.24%
221,706
+4,042
+2% +$709K
DIS icon
94
Walt Disney
DIS
$170B
$40.9M 0.24%
425,698
+157
+0% +$14.4K
ED icon
95
Consolidated Edison
ED
$42B
$40.8M 0.23%
391,755
-73,771
-16% -$7.3M
EQIX icon
96
Equinix
EQIX
$102B
$40.4M 0.23%
45,558
-20,435
-31% -$16.7M
BALL icon
97
Ball Corp
BALL
$17.8B
$40.4M 0.23%
594,541
+9,964
+2% +$633K
VRT icon
98
Vertiv
VRT
$103B
$40M 0.23%
402,198
+132,491
+49% +$11M
BSX icon
99
Boston Scientific
BSX
$69.2B
$39.8M 0.23%
474,915
+38,174
+9% +$3.01M
RARE icon
100
Ultragenyx Pharmaceutical
RARE
$2.56B
$39.6M 0.23%
713,092
+24,150
+4% +$1.23M
2 3
4
5 6

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.